The number of preliminary or unsubstantiated treatments or risk factors for the coronavirus is increasing. Here’s one reason why.
Academic rigor, journalistic flair
Articles on Pre-print servers
Displaying all articles
In our institutions of higher education and our research labs, scholars first produce, then buy back, their own content. With the costs rising and access restricted, something’s got to give.
The traditional mode of publishing scientific research faces much criticism – primarily for being too slow and sometimes shoddily done. Maybe fewer publications of higher quality is the way forward.
Top contributors
-
Visiting Fellow, Australian National Centre for the Public Awareness of Science, Australian National University
-
Dean of the College of Natural Sciences, Professor of Biochemistry and Molecular Biology, UMass Amherst
-
Dean of Libraries and Vice President for Information Technology, Colorado State University
